1620 Investment Advisors, Inc. Teva Pharmaceutical Industries LTD Transaction History
1620 Investment Advisors, Inc.
- $126 Million
- Q4 2024
A detailed history of 1620 Investment Advisors, Inc. transactions in Teva Pharmaceutical Industries LTD stock. As of the latest transaction made, 1620 Investment Advisors, Inc. holds 82 shares of TEVA stock, worth $1,332. This represents 0.0% of its overall portfolio holdings.
Number of Shares
82
Previous 82
-0.0%
Holding current value
$1,332
Previous $1,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding TEVA
# of Institutions
671Shares Held
571MCall Options Held
21.1MPut Options Held
9.94M-
Black Rock Inc. New York, NY43MShares$699 Million0.02% of portfolio
-
Clal Insurance Enterprises Holdings LTD Tel Aviv, L339MShares$633 Million7.75% of portfolio
-
Ion Asset Management Ltd. George Town, Grand Cayman, E936.7MShares$596 Million48.01% of portfolio
-
Menora Mivtachim Holdings Ltd.28.4MShares$461 Million3.94% of portfolio
-
Exor Capital LLP London, X027.2MShares$442 Million17.5% of portfolio
About TEVA PHARMACEUTICAL INDUSTRIES LTD
- Ticker TEVA
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 1,110,560,000
- Market Cap $18B
- Description
- Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...